TrialThe journal of prevention of Alzheimer's disease2022

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial.

M M Gonzales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.